Cardiovascular 1
Cardiovascular 2
Cardiovascular 3
Cardiovascular 4
Cardiovascular 5
100

Most common cause of tricuspid stenosis

Rheumatic disease

100

Primary diagnostic test for evaluation of HF

Echocardiography

100

Most common tachycardia, typically related to physiologic demand

Sinus tachycardia

100

Drug options available for high-intensity statin

Atorvastatin, 40-80 mg/d; rosuvastatin, 20-40 mg/d

100

Fixed split S2, right axis deviation, incomplete RBBB

Ostium secundum ASD

200

Primary symptoms of severe aortic stenosis

Dyspnea, angina, syncope

200

Drug treatment for tricuspid regurgitation with right HF

Loop diuretics and aldosterone antagonists

200

Diagnostic testing option for infrequent symptomatic palpitations or syncope

Ambulatory ECG monitor or event recorder

200

Strategy to avoid nitrate tolerance

12-Hour nitrate-free interval

200

Vascular complication of Marfan syndrome during pregnancy

Aortic dissection and rupture

300

Treatment of chronic severe mitral regurgitation with LV dysfunction or dilation

Mitral valve repair

300

Indication for aldosterone antagonist for HFrEF

NYHA functional class II-IV HFrEF or after acute MI

300

Drug therapy for inherited long QT syndrome

β-Blocker

300

Timing of ACE inhibitor and/or ARB initiation after STEMI

Within 24 hours

300

Bridging therapy for hemodynamic instability in cardiac tamponade

Normal saline infusion

400

Surgical indications for chronic aortic regurgitation

Symptoms, LVEF ≤55%, LV dilatation

400

Nonischemic cardiomyopathy ICD indications

LVEF ≤35% and NYHA functional class II-III symptoms

400

ECG findings of acute pericarditis

Multiple-lead ST-segment elevation and PR-segment depression in lead II

400

ABI value diagnostic of PAD

≤0.90

400

Target systolic BP for acute aortic dissection

≤120 mm Hg within 1 hour

500

Contraindications for percutaneous balloon mitral commissurotomy to treat mitral stenosis

Left atrial thrombus, moderate mitral regurgitation, severely calcified valve

500

Imaging to distinguish different subtypes of cardiac amyloid

99m-Technetium pyrophosphate scintigraphy

500

ST-segment coving in leads V1-V3, ventricular tachyarrhythmias, SCD

Brugada syndrome

500

Indications for immediate invasive treatment in non–ST-elevation ACS

Hemodynamic instability, refractory chest pain, HF, arrhythmias

500

Asymptomatic murmurs that require TTE evaluation

Grade ≥3/6, late systolic or holosystolic, diastolic, or continuous